Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

REVEALED: Manipal health - The Real Truth

HSBC initiates coverage on this recently listed healthcare stock that can rally up to 26%. Do you own?

HSBC has initiated coverage on recently listed Manipal Health with a Buy rating and Rs 1,000 target price, implying 26% upside. The brokerage sees strong growth potential from improving hospital utilisation, the Sahyadri turnaround, higher-margin speciality mix and deleveraging, with adjusted PAT expected to nearly triple by FY29.

The Economic Times

Manipal Health shares slide 6% on account of profit booking. What should investors do?

Manipal Health Enterprises shares fell sharply on Thursday day after their strong market debut, triggering profit booking. Analysts remain constructive on the company's long-term prospects but advise fresh investors to wait for better entry levels, citing premium valuations, while allotted investors can continue holding with a stop-loss at Rs 620.

The Economic Times

Manipal Health shares list at 11% premium to beat GMP estimates. What should allotted investors do?

Manipal Health Enterprises shares debuted at an 11% premium over the IPO price, beating grey market expectations. Brokerages remain constructive on the hospital chain's long-term prospects, though some caution that valuations are rich. Here's what experts recommend for allotted investors and those considering fresh entry.

The Economic Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Manipal Health IPO Day 3 Update: GMP remains at 1%, subscription at 45%. Should you Subscribe or Skip?

By the end of Day 2, the IPO had received 45% overall subscription against the 9 crore shares on offer. The retail investor quota was also subscribed 45%, with bids placed for 1.64 crore shares reserved for the segment.

The Economic Times

Manipal Health Enterprises IPO Day 2: GMP holds at 2%, Subscription reaches 15%. Should you Subscribe or Skip?

Manipal Health Enterprises' large IPO is experiencing cautious investor interest on its second day. The grey market premium remains modest, indicating a subdued market sentiment. The company plans to use significant funds for debt repayment and strategic acquisitions. Brokerages largely view Manipal Health's long-term prospects positively, despite premium valuations. The…

The Economic Times

Manipal Health’s Rs 9,275 crore IPO opens for subscription. Should you apply?

Manipal Health Enterprises' Rs 9,275-crore IPO opened for subscription on July 29 with a muted grey market premium of around 2%, signalling limited listing gains. The hospital chain plans to use proceeds to reduce debt and fund acquisitions. While most brokerages recommend subscribing for the long term, several caution that…

The Economic Times

Manipal Health IPO: Co. garners Rs 4,167 crore from anchor investors; ADIA, Morgan Stanley among investors

Manipal Health Enterprises secured Rs 4,167 crore from anchor investors for its upcoming IPO. The company's initial public offering is set to launch on July 29, aiming for Rs 9,275 crore. This public issue will include a fresh issue and an offer for sale by existing shareholders. Funds raised will…

The Economic Times

Read news from The Economist, FT, and more,
with one subscription

IPO rush: 9 companies to launch issues on D-St this week, raising over Rs 11,000 cr

India's primary market is gearing up for a hectic week, with nine IPOs set to open across the mainboard and SME segments. The mainboard will feature issues from Manipal Health Enterprises, Juniper Green Energy and MV Electrosystems, collectively aiming to raise over Rs 11,300 crore, led by Manipal Health's Rs…

The Economic Times

India's Manipal Health to spend $414.4 million to expand capacity

Manipal Health Enterprises plans to investRs 4,000 croreover the next 3–4 years to add2,400 hospital beds, expanding its capacity by over 18%, ahead of its IPO next week. The Temasek-backed hospital chain is also targeting a valuation of up to$8 billionand aims to becomenet debt-freeusing IPO proceeds.

The Economic Times

Manipal Health IPO: How an acquisition spree will consume most of its Rs 8,000 crore fresh issue

Manipal Health Enterprises will use over three-fourths of its Rs 8,000 crore fresh IPO proceeds to repay acquisition-related debt and fund an additional stake purchase in Sahyadri Hospitals. The issue reflects a balance-sheet reset after an aggressive expansion strategy that significantly increased debt while expanding its hospital network.

The Economic Times

Manipal Health Enterprises IPO: GMP hints at 10% listing gains; know important dates, other details

Manipal Health Enterprises, backed by Temasek and Ranjan Pai, will open its Rs 9,275-crore IPO for subscription on July 29 at a price band of Rs 560-590 per share. The issue comprises a fresh issue of Rs 8,000 crore and an OFS worth Rs 1,275.2 crore. The Bengaluru-based hospital chain…

The Economic Times

Byju's lenders seek 30% stake in Indian education group in settlement

Byju's operated in more than 21 countries at one point and became ‌popular during ⁠the COVID-19 ⁠pandemic by offering online courses. But its fortunes changed in early 2023 when the high-profile dispute with its U.S.-based lenders began.

The Economic Times

PE wars to billion-dollar IPO dreams, hospital sector is fighting fit

Major private equity firms are vying for a stake in Cloudnine, a leading maternity and paediatric care chain. This intense competition highlights strong investor confidence in India's healthcare sector. The industry is entering a new growth phase driven by increasing demand, a shortage of hospital beds, and a rise in…

The Economic Times

People

Byju Raveendran

29 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Manipal Health Enterprises

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.